ReviewSurgical neurology international2026
Repetitive transcranial magnetic stimulation for neuropathic pain and neuropsychiatric sequelae in traumatic brain injury: A meta-analysis and trial sequential analysis.
Review in Surgical neurology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Non-invasive brain stimulation for cognitive impairment after traumatic brain injury: an umbrella review of systematic reviews.Frontiers in neurology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Traumatic brain injury (TBI) is a major cause of long-term disability, often leading to chronic neuropathic pain and neuropsychiatric symptoms. These complications significantly impair quality of life and are often resistant to conventional treatments. Repetitive transcranial magnetic stimulation (rTMS), a non-invasive neuromodulation technique, has shown promise in treating both neuropathic pain and psychiatric disorders in various neurological conditions. However, its efficacy and safety in the TBI population remain unclear. This study aims to evaluate the effectiveness of rTMS in managing neuropathic pain and neuropsychiatric symptoms in individuals with TBI. Methods: Articles were systematically retrieved from databases using keywords "traumatic brain injury," "rTMS," "neuropathic pain," and "neuropsychiatric symptoms." Eligible studies included randomized controlled trials involving TBI patients treated with rTMS. The risk of bias (RoB) was evaluated using the RoB 2.0. Trial sequential analysis (TSA) of pooled analysis that is significant and consisted of more than one studies was done. Results: A total of nine studies involving patients with TBI were included. rTMS significantly reduced post-concussive symptoms on Rivermead post-concussion questionnaire (RPQ) 13 (standardized mean difference [SMD] -0.67; Conclusion: rTMS may provide short-term benefits in reducing neuropathic pain and potentially for post-concussive symptoms in patients with TBI. More studies are needed to confirm the benefits of using rTMS for post-concussive and neuropsychiatric symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.